Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Octavio Espinoza Insider Profile
4 Followers
Octavio Espinoza, CFO at Ligand Pharma, holds 24.61K shares in Ligand Pharma (Ticker: LGND). Most recently, Octavio Espinoza Sold $1,275 shares of Ligand Pharma on Sep 24, 2024 for an estimated value of 132.52K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-18.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Octavio Espinoza's holdings
Insider Roles
CFO
Roles that Octavio Espinoza holds in companies
Most Profitable Insider Trade
The most profitable trade made by Octavio Espinoza
Octavio Espinoza's Trading History
List of latest transactions for each holding click on a transaction to see Octavio Espinoza's performance on stock
You May Also Like
Octavio Espinoza insider profile FAQ
What is the percentage of profitable transactions made by Octavio Espinoza?
The percentage of profitable transactions made by Octavio Espinoza is 25%.
What is the average return per transaction made by Octavio Espinoza?
The average return per transaction made by Octavio Espinoza is -18.90%.
What stocks does Octavio Espinoza hold?
Octavio Espinoza holds: LGND stocks.
What was Octavio Espinoza’s latest transaction?
Octavio Espinoza latest transaction was an Informative Sell of $132.52K.
What was Octavio Espinoza's most profitable transaction?
Octavio Espinoza’s most profitable transaction was an Informative Sell of LGND stock on November 10, 2022. The return on the trade was 32.40%.
What is Octavio Espinoza's role in Ligand Pharma?
Octavio Espinoza's role in Ligand Pharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.